Evidence map›Paper›PMID 42182420›Full record

ArticlebioRxiv : the preprint server for biology2026

Engineering high-titer lentiviral vectors for robust expression of RNA-based gene circuits.

Kasey S Love, Brittany A Lende-Dorn, Kate E Galloway

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kasey S LoveDepartment of Biological Engineering, MIT, 25 Ames St., Cambridge, MA 02139, USA.ORCID 0000-0001-7544-0340
Brittany A Lende-DornDepartment of Chemical Engineering, MIT, 25 Ames St., Cambridge, MA 02139, USA.ORCID 0000-0003-4107-7648
Kate E GallowayDepartment of Chemical Engineering, MIT, 25 Ames St., Cambridge, MA 02139, USA.ORCID 0000-0001-7416-3193

Funding

Multiscale tools and approaches for understanding and engineering cell-fate transitionsR35GM143033 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GALLOWAY, KATE ELIZABETH · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM143033
6 · The paper itself

Abstract

Lentiviral vectors enable efficient delivery of genetic cargoes for gene and cell therapies. With their ~10-kb packaging limit, lentiviral vectors can encode multiple transcription units, supporting delivery of compact gene circuits. RNA-based devices offer highly compact control including ligand-responsive induction and closed-loop regulation. However, RNA devices such as ribozymes and splicing switches may interfere with vector production via activity on the single-stranded RNA genome. Here, we examine the impact of gene syntax and genetic parts to define design strategies for two-gene vectors encoding RNA devices. We find that titer decreases with genetic parts that interfere with transcription or processing of the viral transcript during production. Compared to initial vectors, our best-performing design boosts titer more than 30-fold, enabling fine-scale tuning of expression to optimize cell-fate conversion within a non-monotonic landscape. Together, this work illuminates principles for constructing two-gene lentiviral vectors with both high titer and robust expression, enhancing efficacy for downstream applications.

Identifiers

PMID42182420
PMCPMC13192699

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.